USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11072
Full metadata record
DC FieldValueLanguage
dc.contributor.authorManvelov, Anastasia
dc.date.accessioned2020-07-07T11:32:50Z
dc.date.available2020-07-07T11:32:50Z
dc.date.issued2016
dc.identifier.citationMANVELOV, Anastasia. Clinico-evolutional particularities of the metabolicsyndrome in gout. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p. 103-104.en_US
dc.identifier.isbn978-9975-3028-3-8.
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11072
dc.descriptionDepartment of Internal Medicine, Rheumatology and Nephrology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016en_US
dc.description.abstractIntroduction: The prevalence of gout has increased in recent decades in most of the countries, but the growth of gout in the developed countries has been linked to changing lifestyles and refuse to traditional diet. Metabolic syndrome is Associated with many diseases, some of them have evolutionally grievous potential. It was found that metabolic syndrome exists in presence of gout. It is very important to know the risk factors, to take some measures for the disease prevention. Purpose: to study clinical-evolutional particularities of the metabolic syndrome in gout and to determinate risk factors for such patients. Materials and Methods: 50 patients were analyzed according to the gout classification criteria. Patients were hospitalized in Rheumatology and Arthrology Departments of Republican Clinical Hospital. Patients average age was 48.2, and the average duration of disease - 5.1 years. Results: It was found that 50 (100%) patients had arthritis and 41 (82%) patients had metabolic syndrome. The following risk factors were identified: overweight and obesity in 41 (82%) patients, high blood pressure and drugs taking in 32 (64%) patients, alcohol - 29 (58%) and diet rich in meat - 26 ( 52%). Conclusion: the gout diagnosis must be accompanied by thorough assessment of the metabolic syndrome components: high blood pressure, insulin resistance, dyslipidemia, abdominal obesity. It was determined that gout represents independent cardiovascular risk factor, which increase the risk of heart attack. Hypocalorical diet at patients who have dyslipidemia do not decrease only serum lipid level, butalso uric acid level; by increasing renal excretion of urate. Thus, change of lifestyle have a significant effect on the disease evolution, recommending to reduce purine-rich foods and alcohol consumption.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectgouten_US
dc.subjectmetabolic syndromeen_US
dc.subjectobesityen_US
dc.subjecthigh blood pressureen_US
dc.titleClinico-evolutional particularities of the metabolicsyndrome in gouten_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2016

Files in This Item:
File Description SizeFormat 
Clinico_evolutional_particularities_of_the_metabolicsyndrome_in_gout.PDF38 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback